Joan Cox Gill, MD

Hematology/Oncology

Title(s): Professor, Pediatrics and Medicine, Medical College of Wisconsin; director, Hemophilia Center, Children's Hospital of Wisconsin; director, Comprehensive Center for Bleeding Disorders, BloodCenter of Wisconsin; investigator, Blood Research Institute, BloodCenter of Wisconsin.

Education: Medical degree, Medical College of Wisconsin, Milwaukee, 1976; residency, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee, 1978; fellowship, Medical College of Wisconsin, Children's Hospital of Wisconsin and The Blood Center, Milwaukee, 1981.

Certification(s): American Board of Pediatric Hematology/Oncology, American Board of Pediatrics.

Honors: 1992 visiting professor, Columbus Children's Hospital, Columbus, Ohio; 1995 visiting professor, Mayo Clinic, Rochester, Minn.; visiting professor, University Medical Center, Jackson, Miss.; Best Doctors in America, 1996-present.

Research interests: Hemophilia, hemophilic inhibitors, von Willebrand disease, thrombosis, hepatitis C and HIV.

Representative publications:

• Gill JC, Endres‑Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The Effect of ABO Blood Group on the Diagnosis of Von Willebrand Disease. Blood 69: 1691‑96, 1987.
• Eckels DD, Tabatabai N, Bian TH, Wang H, Muheisen SS, Rice CM, Yoshizawa K, Gill JC. In Vitro Human T-Cell Responses to a Recombinant Hepatitis C Virus Antigen: Failure in IL-2 Production Despite Proliferation. Human Immunolology, 60, 187-199, 1999.
• Gill JC. The Role of Genetics in Inhibitor Formation. Thrombosis Haemostasis, 82:500-505, 1999.
• Punzalan RC, Hillery CA, Montgomery RR, Scott JP, Gill JC. Low Molecular Weight Heparin (Enoxaparin) in Thrombotic Disease in Children and Adolescents. American Journal of Pediatric Hematology Oncology 22:137-142, 2000.
• Gill JC, Ottum M, Schwartz B. Evaluation of High Concentration Intranasal and Intravenous Desmopressin in Pediatric Patients with Mild Hemophilia A or Mild-to-Moderate Type 1 von Willebrand Disease. Journal of Pediatrics 140:595-599, 2002.
• Gill JC. Diagnosis and Treatment of von Willebrand Disease. Hematology/Oncology Clinics of North America. 18:1277-1299, 2004.

Current grants:

• Region V-West Hemophilia Treatment Center Network, Director of Regional Center, The Comprehensive Center for Bleeding Disorders, 10/01/96-9/30/05.
• Prevention of the Complications of Hemophilia through Hemophilia Treatment Centers, Director of Regional Center, The Comprehensive Center for Bleeding Disorders, 10/01/96-9/30/05.

Contact information: PO Box 1997, Milwaukee, WI 53201. Phone: (414) 257-2424. Fax: (414) 937-6580. E-mail: coxgillj@mcw.edu.